Lung Function Lab, National Research Institute of TB & Lung Diseases, Warsaw, Poland.
COPD. 2012 Jun;9(3):213-5. doi: 10.3109/15412555.2012.669434. Epub 2012 Apr 4.
Airway reversibility test (or bronchodilatation test) is performed routinely in the diagnosis of obstructive lung diseases. The results of this test may be helpful in the diagnosis and differential diagnosis of asthma and chronic obstructive pulmonary disease (COPD), but sometimes bring confusion. Unfortunately, the nomenclature used for test result is not uniform, which also leads to confusion. Next the reader will find an attempt to order the state of affairs and the introduction of a uniform nomenclature, which would be consistent with the logic and allow for unambiguous classification of reversibility test results to facilitate future decisions based on the differential diagnosis.
气道可逆性试验（或支气管扩张试验）常用于阻塞性肺疾病的诊断。该试验的结果可能有助于哮喘和慢性阻塞性肺疾病（COPD）的诊断和鉴别诊断，但有时也会带来困惑。不幸的是，用于测试结果的命名法并不统一，这也导致了混淆。接下来，读者将发现一种尝试对现状进行排序并引入统一命名法的方法，这将符合逻辑，并允许对可逆性试验结果进行明确分类，以便根据鉴别诊断做出未来决策。
